Marpai, Inc. (OTCQX: MRAI), a healthcare technology, third-party administration and pharmacy benefit management business, has entered into securities purchase agreements with accredited investors in a private placement of newly designated convertible preferred stock. The offering was led by Mitchell Companies.
The company states that the $12 million investment is intended to accelerate its growth trajectory, strengthen its technology-enabled healthcare services platform and improve its financial position.
Marpai's stated focus is on serving self-funded employers, members, brokers and healthcare partners through more efficient administration of health plans.
The securities described in the announcement were offered in a private placement to accredited investors and have not been registered under the Securities Act of 1933. The announcement does not constitute an offer to sell or a solicitation of an offer to buy.
Private placements of this size are one of the routes through which family offices and private investment platforms take positions in listed micro-cap companies. Convertible preferred structures typically sit ahead of common equity while retaining upside participation, which is part of their appeal to investors underwriting operational turnarounds.
UKFOS Editorial · 31 JULY 2026